$SGMT 8-K SEC Filings

Filed On	Filing
22 Oct 2026	8-K: Regulation FD Disclosure Targeting Metabolic Dysfunction with Novel Therapeutics October 2026 Exhibit 99.1
01 Oct 2026	8-K: Entry into a Material Definitive Agreement On September 30, 2026, Sagimet Biosciences Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Leerink Partners LLC, TD Securities (USA) LLC and Guggenheim Securities, LLC as representatives of...
30 Sep 2026	8-K: Regulation FD Disclosure; Other Events Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
13 Aug 2026	8-K: Other Events
11 Aug 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
21 Jul 2026	8-K: Regulation FD Disclosure
12 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
03 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation
12 May 2026	8-K: Results of Operations and Financial Condition
28 Apr 2026	8-K: Entry into a Material Definitive Agreement
27 Apr 2026	8-K: Regulation FD Disclosure
27 Apr 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure +1 more
21 Apr 2026	8-K: Departure/Election of Directors or Officers; Compensation; Other Events
11 Mar 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
02 Feb 2026	8-K: Regulation FD Disclosure
18 Dec 2025	8-K: Regulation FD Disclosure; Other Events
17 Dec 2025	8-K: Other Events
13 Nov 2025	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
23 Oct 2025	8-K: Regulation FD Disclosure
22 Aug 2025	8-K: Changes in Registrant's Certifying Accountant

Comments